Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL435807

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
CO[C@H]1C[C@H](C)CC2=C(NC3CC3)C(=O)C=C(NC(=O)/C(C)=C/CC[C@H](OC)[C@@H](OC(N)=O)/C(C)=C/[C@H](C)[C@H]1O)C2=O

Basic Information

ChEMBL ID CHEMBL435807
Phase Preclinical
Structure Type MOL
InChI Key GAMKUBTXTYVVGV-DFWLXACVSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names

Molecular Properties

587.7
MW (Da)
2.74
ALogP
9
HBA
4
HBD
166.3
PSA (Ų)
0.28
QED
1
Ro5 Violations
5
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C31H45N3O8
MW 587.71
Aromatic Rings 0
Heavy Atoms 42
NP-Likeness 2.02

Activity Summary

IC50 1 meas. best 7.34

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
SK-BR-3
CHEMBL613834
IC50 7.34 7.34 46.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
SK-BR-3 IC50 = 46.0 nM 7.34 Inhibition of oncogene product p185 erbB-2 from human breast cancer cells(SK-BR-... 7562911

Literature References

PubMed DOI Target Context # Activities
7562911 10.1021/jm00019a010 SK-BR-3 2

Data from ChEMBL 36 via Core Engine